RECURSION PHARMACEUTICALS, INC. reports financial results in SEC 8-K

RECURSION PHARMACEUTICALS, INC. filed an 8-K covering results of operations or financial condition, director or executive-officer changes, and a Regulation FD disclosure. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.